




































Hormesis (a neologism coined from the ancient Greek 
term hormáein, which literally means "to set in motion, 
impel, urge on") describes a favorable biological 
response to harmless doses of toxins and other stressors. 
Hormesis-stimulating compounds initiate an adaptive 
stress response that renders cells/organisms resistant 
against high (and normally harmful) doses of the same 
agent. On the theoretical level, hormesis may constitute 
(one of) the mechanisms that allows stressed cells to 
avoid senescence and death, and hence might have 
some impact on the (patho)physiology of aging. Thus, 
measures that reportedly prolong the healthy lifespan of 
multiple species, such as caloric restriction and the 
administration of resveratrol [1-6], may do so by 
inducing a hormetic response [7, 8].  In  this  article,  we  
 
 




































will examine the molecular circuitries that link cellular 
stress and death, and how these pathways can get 
uncoupled during hormetic responses.  
 
Redundant pathways leading to apoptotic cell death 
 
Apoptosis is frequently viewed as a caspase-dependent 
cell death pathway in which a series of specific cysteine 
proteases are activated in a cascade of proteolytic 
maturation steps [9, 10]. In response to cell death-
inducing signals, so-called initiator caspases (i.e., 
caspase-8 and -9) [11, 12] get engaged and activate so-
called effector caspases (i.e., caspase-3, -6 and -7) [13], 
which in turn degrade multiple proteins causing the 
arrest of vital cellular functions as well as the initiation 
of lethal catabolic reactions [14-16]. Two upstream 






























mitochondria.  When  high  doses  of  these  agents  are  employed,  cells  undergo  mitochondrial  outer  membrane
permeabilization and die. In contrast, low doses of such cytotoxic agents can activate hormesis in several paradigms, and
this may explain the lifespan‐prolonging potential of autophagy inducers including resveratrol and caloric restriction.  
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gets activated within the death-inducing signaling 
complex (DISC), a multiprotein complex that forms 
at the cytoplasmic tails of a specific class of cell 
surface receptors, the death receptors, upon their 
occupancy by their respective ligands [12, 17-19]. In 
the intrinsic pathway, caspase-9 is activated at the so-
called apoptosome, a supramolecular entity that 
involves dATP, the cytoplasmic protein APAF1 and 
the mitochondrial intermembrane space factor 
cytochrome  c, and that only forms when the outer 
mitochondrial membrane, which usually separates 
APAF1 (outside) and cytochrome c  (inside) is 
permeabilized [20-24].  
 
Nonetheless, caspase inhibition rarely prevents cell 
death completely (although it sometimes attenuates the 
morphological manifestations of apoptosis) [10, 25-27], 
and multiple caspase-independent pathways may come 
into action [9, 28, 29]. For example, permeabilized 
mitochondria can allow for the release of apoptosis-
inducing factor (AIF) and cofilin, both of which have 
been shown to operate as caspase-independent death 
effectors [30-33]. This places the control of cell death at 
the level of the mitochondrion, and more precisely at 
the level of mitochondrial membranes, whose 
permeabilization is controlled by multiple upstream 
effectors and processes, including distinct classes of 
stress-activated kinases [24, 34-43], the tumor 
suppressor protein p53 [44-46], epigenetic perturbations 
[47-51], (de)acetylases [52, 53], perturbations of the cell 
cycle [54, 55], and nuclear damage [56-60].  
 
In accord with the key role of mitochondria in the 
regulation of many (if not all) apoptotic pathways [61-
65], mitochondrial functions and integrity are controlled 
by a variety of distinct mechanisms. Proteins from the 
Bcl-2 family are considered as central modulators of 
mitochondrial apoptosis [66-68], but other proteins that 
are not directly related to BCL-2 can induce or suppress 
mitochondrial outer membrane permeabilization 
(MOMP) as well. Thus, beyond BCL2 and its close 
relatives BCL2L1 (best known as Bcl-XL) and MCL1, 
PRELI [69], the uncoupling protein 2 (UCP2) [70] and 
the X-linked inhibitor of apoptosis protein (XIAP) [22] 
can prevent MOMP. Pro-apoptotic proteins like the 
multidomain proteins BAX and BAK [71], as well as 
multiple BH3-only proteins stimulate MOMP [72-74]. 
In addition, pro-oxidants [75-77], membrane-
destabilizing lipids (such as ceramide) [52] and free 
Ca
2+ ions (modulated by other divalent cations such as 
Mg
2+ and Zn
2+, and possibly by the monovalent cation 
Li
+) [21, 23, 78-80] can stimulate MOMP.  
 
 
Autophagy as a cytoprotective mechanism  
 
Macroautophagy (to which we refer to as “autophagy”) 
is a lysosomal degradation pathway in which portions of 
the cytoplasm (organelles or cytosol) are enwrapped in 
double-membraned vesicles (called autophagosomes) 
that fuse with lysosomes and get degraded by lysosomal 
hydrolases [81-84]. Importantly, autophagy and 
apoptosis exhibit a consistent degree of crosstalk, at 
multiple levels [85-87]. 
 
Autophagy can lead to the removal of damaged, 
potentially dangerous mitochondria, thereby increasing 
the threshold for cell death induction by MOMP-
inducing agents or other stressors. Thus, both 
mitochondrion-specific autophagy (mitophagy) and 
general autophagy can reduce the propensity of cells to 
undergo apoptosis [1, 76, 88-90].  
 
Caspase-dependent apoptosis is associated with the 
degradation of Beclin 1 by caspases. As Beclin 1 is 
essential for the initial steps of autophagy, caspase 
activation most often result into the inhibition of the 
autophagic pathway [16, 91, 92]. This reflects a general 
pattern according to which pro-apoptotic signals result 
in the inhibition of pro-survival systems.  
 
Some molecular mechanisms that sense cellular stress 
can induce both autophagy and apoptosis. This applies 
for instance to BH3 proteins (as well as 
pharmacological BH3 mimetics), which can liberate 
Beclin 1 from inhibitory interactions with BCL-2-like 
proteins, thereby favoring autophagy, and also stimulate 
MOMP by activating BAX or BAK [93-101]. It is 
thought that the relative abundance of different Bcl-2 
family members, as well as their subcellular localization 
and activation state may determine whether BH3 
proteins/mimetics induce autophagy or apoptosis [66, 
67]. Moreover, endoplasmic reticulum stress can either 
result in autophagy or in apoptosis, depending on a yet-
to-elucidated interplay among threshold effects [88, 
102, 103]. One possible scenario suggests that mild 
stress would induce an autophagic response that 
elevates the threshold for apoptosis induction. This 
would represent a typical case of hormesis (Figure 1).  
 
Autophagy as an anti-aging mechanism  
 
Pharmacological or genetic manipulations designed to 
prolong lifespan induce autophagy in multiple model 
organisms, including yeast, nematodes and flies, and the 
inhibition of autophagy often (always?) prevents 
longevity  extension  in  such  settings.  This  applies  to  
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genetic or pharmacological activation of Sirtuin 1, 
inhibition of the mammalian target of rapamycin 
(mTOR) with rapamycin, and administration of 
spermidine, a histone acetylase inhibitor [3, 4, 81, 104-
107]. Among these stimuli, there is circumstantial 
evidence that Sirtuin 1 (whose activation occurs during 
and is necessary for starvation- and resveratrol-
induced autophagy) acts in a hormetic fashion. One of 
the best-known systems of hormesis is ischemic 
preconditioning (IPC), whereby short episodes of 
ischemia protect the brain against a later, more severe 
reduction in oxygen and nutrient supply. In this 
system, the administration of resveratrol can mimic 
IPC, and both resveratrol and IPC induce similar 







































It is currently a mystery through which mechanisms 
autophagy may increase lifespan [108, 109]. One obvious 
possibility resides in the cytoprotective, apoptosis-
inhibitory action of autophagy (see above), although 
other possibilities must be considered as well. For 
example, there is ample evidence that the inhibition of 
mTOR (which stimulates autophagy, yet may have other 
metabolic effects as well) antagonizes senescence [105, 
110-115]. Thus, it can be speculated, yet remains to be 
proven, that autophagy would avoid cellular senescence 
induced by DNA-damaging agents [116-119], as well as 
the attrition of stem cells that accompanies advanced 
aging [120-123]. Simultaneously, there is strong evidence 
indicating that autophagy functions as an onco-
suppressive mechanism that avoids the genetic instability 








































Figure  1.  Autophagy  and  hormesis.  In  baseline  conditions,  autophagy  contributes  to  the





provoke  a  hormetic  response  and  hence  favor  the  adaptation  of  cells  to  stress  (B).  MOMP,
mitochondrial outer membrane permeabilization. 
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aggregate-prone cellular proteins, thus reducing the 
abundance of potent neurotoxic factors including, but 
not limited to, huntingtin aggregates [131]. Whether the 
induction of autophagy may also affect the 
accumulation of potentially toxic extracellular proteins 
(such as amyloid β and others) remains to be clarified 
[32, 132-134].  
 
At this stage, it is not clear which (if any) among these 
putative mechanisms plays a preponderant role in the 
longevity-increasing potential of autophagy. Future 
work will have to clarify this issue, which may have a 
major impact on how we design strategies for 
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